Optimizing CGM Use and Metabolic Outcomes in Youth with Type 1 Diabetes
Optimizing CGM Use and Metabolic Outcomes in Youth with Type 1 Diabetes
批准号:
8324657
负责人:
LORI M LAFFEL
金额:
$67.17万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-30 至 2014-08-31
关键词:
17 year oldAddressAdherenceAdolescentAdultAgeAnxietyArtificial PancreasBehavior TherapyBehavioralBlood GlucoseBlood VesselsCalibrationChildChildhoodClinical TrialsComplications of Diabetes MellitusDataDiabetes MellitusDoseDropsEffectivenessEpidemiologyFaceFamilyFoundationsFrequenciesFrightFutureGlucoseGlycosylated hemoglobin AGoalsGrowthGrowth and Development functionHumanHypoglycemiaInsulinInsulin-Dependent Diabetes MellitusInterventionInvestigationMeasuresMetabolicMetabolic ControlModelingMonitorMotivationOutcomePatientsPersonsPhysiologicalPopulationPubertyPublishingPumpRandomizedRandomized Controlled Clinical TrialsReportingResearchRiskRisk ReductionSelf EfficacySystemTechniquesTechnologyTherapeuticWeight GainYouthanalogbehavioral healthbeta cell replacementburnoutcostdepressive symptomsdesigndiabetes controlevidence baseexperiencefollow-upglucose monitorglycemic controlhealth related quality of lifeimprovedlorismonitoring devicemotivational enhancement therapyprimary outcomeprospectivepsychologicpsychological outcomespublic health relevanceresponsesensorstandard caretrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The availability of continuous glucose monitoring (CGM) technologies provides opportunities to achieve target hemoglobin A1c (A1c) levels for persons with type 1 diabetes (T1D). Until there is a fully automated closed- loop insulin delivery system, human motivation and stamina for implementation and sustained use of CGM devices are necessary. The recently published study by the Juvenile Diabetes Research Foundation (JDRF) CGM Study Group demonstrated significant improvements in A1c without an increase in hypoglycemia in adult patients using CGM compared to standard BG monitoring. Young persons with T1D randomized to CGM did not experience the same benefits as adults randomized to CGM. However, pediatric patients who used CGM consistently did experience the same improvements in A1c as adults. Unfortunately, the greatest non- adherence to CGM occurred in 8-17 year olds. In this application, we seek to realize the benefits of CGM for improving metabolic control and reducing severe hypoglycemia in youth ages 8-17 with T1D. In a prospective, randomized, controlled clinical trial, we will assign 120 youth with T1D of duration >=1 year to 1 of 2 groups: (1) CGM implemented according to standard care (CGM-SC) or (2) CGM implemented with a manualized, family- focused teamwork intervention administered using motivational interviewing techniques to overcome recognized barriers to CGM use (CGM-TW). The 2-year clinical trial will provide an opportunity to evaluate longer-term use of CGM and its associated metabolic and behavioral outcomes in pediatric patients with T1D. Completion of this trial will provide previously unavailable data regarding the longer-term efficacy and effectiveness of CGM implemented with and without a family-focused, behavioral teamwork intervention that encourages CGM implementation and sustained use. The overall aim is to improve metabolic control and preserve behavioral health/psychological outcomes in children and adolescents with T1D in this application entitled, "Optimizing CGM Use and Metabolic Outcomes in Youth with Type 1 Diabetes".
PUBLIC HEALTH RELEVANCE: Continuous glucose monitoring (CGM) improves glycemic control without increasing hypoglycemia in adults with type 1 diabetes (T1D); youth with T1D do not experience equivalent benefit. This application will design, implement, and evaluate a family-focused behavioral intervention to encourage sustained CGM use in pediatric patients with T1D in order for them to realize the glycemic benefits afforded to adult patients using this technology. The current application will evaluate the long-term acceptability and durability of CGM, and assess the metabolic outcomes and behavioral impact of CGM on pediatric patients with T1D and their families.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CAREER DEVELOPMENT IN DIABETES RESEARCH FOR PEDIATRIC ENDOCRINOLOGISTS
-
批准号:8728223
-
项目类别:
-
资助金额:$57.2万
-
财政年份:2011
-
负责人:LORI M LAFFEL
-
依托单位:
CAREER DEVELOPMENT IN DIABETES RESEARCH FOR PEDIATRIC ENDOCRINOLOGISTS
-
批准号:8261582
-
项目类别:
-
资助金额:$58.94万
-
财政年份:2011
-
负责人:LORI M LAFFEL
-
依托单位:
CAREER DEVELOPMENT IN DIABETES RESEARCH FOR PEDIATRIC ENDOCRINOLOGISTS
-
批准号:8333424
-
项目类别:
-
资助金额:$58.74万
-
财政年份:2011
-
负责人:LORI M LAFFEL
-
依托单位:
CAREER DEVELOPMENT IN DIABETES RESEARCH FOR PEDIATRIC ENDOCRINOLOGISTS
-
批准号:10399893
-
项目类别:
-
资助金额:$56.6万
-
财政年份:2011
-
负责人:LORI M LAFFEL
-
依托单位:
CAREER DEVELOPMENT IN DIABETES RESEARCH FOR PEDIATRIC ENDOCRINOLOGISTS
-
批准号:9768427
-
项目类别:
-
资助金额:$56.6万
-
财政年份:2011
-
负责人:LORI M LAFFEL
-
依托单位:
CAREER DEVELOPMENT IN DIABETES RESEARCH FOR PEDIATRIC ENDOCRINOLOGISTS
-
批准号:8508689
-
项目类别:
-
资助金额:$58.27万
-
财政年份:2011
-
负责人:LORI M LAFFEL
-
依托单位:
Optimizing CGM Use and Metabolic Outcomes in Youth with Type 1 Diabetes
-
批准号:8043454
-
项目类别:
-
资助金额:$81.44万
-
财政年份:2010
-
负责人:LORI M LAFFEL
-
依托单位:
Optimizing CGM Use and Metabolic Outcomes in Youth with Type 1 Diabetes
-
批准号:8538952
-
项目类别:
-
资助金额:$63.24万
-
财政年份:2010
-
负责人:LORI M LAFFEL
-
依托单位:
Optimizing CGM Use and Metabolic Outcomes in Youth with Type 1 Diabetes
-
批准号:8147728
-
项目类别:
-
资助金额:$67.18万
-
财政年份:2010
-
负责人:LORI M LAFFEL
-
依托单位:
CLINICAL TRIAL: TREATMENT OPTIONS FOR TYPE 2 DIABETES IN ADOLESCENTS AND YOUTH (
-
批准号:7718965
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2008
-
负责人:LORI M LAFFEL
-
依托单位:
TREATMENT OPTIONS FOR TYPE 2 DIABETES IN ADOLESCENTS AND YOUTH (TODAY)
-
批准号:7606997
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2007
-
负责人:LORI M LAFFEL
-
依托单位:
TREATMENT OPTIONS FOR TYPE 2 DIABETES IN ADOLESCENTS AND YOUTH (TODAY)
-
批准号:7205241
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2005
-
负责人:LORI M LAFFEL
-
依托单位:
Training Grant in Diabetes for Pediatric Endocrinologis*
-
批准号:6897551
-
项目类别:
-
资助金额:$11.28万
-
财政年份:2002
-
负责人:LORI M LAFFEL
-
依托单位:
Training Grant in Diabetes for Pediatric Endocrinologis*
-
批准号:7079358
-
项目类别:
-
资助金额:$12.07万
-
财政年份:2002
-
负责人:LORI M LAFFEL
-
依托单位:
Career Development in Diabetes for Pediatric Endocrinolo
-
批准号:6895268
-
项目类别:
-
资助金额:$40.34万
-
财政年份:2002
-
负责人:LORI M LAFFEL
-
依托单位:
Training Grant in Diabetes for Pediatric Endocrinologis*
-
批准号:6762376
-
项目类别:
-
资助金额:$9.25万
-
财政年份:2002
-
负责人:LORI M LAFFEL
-
依托单位:
Career Development in Diabetes for Pediatric Endocrinolo
-
批准号:7441191
-
项目类别:
-
资助金额:$74.79万
-
财政年份:2002
-
负责人:LORI M LAFFEL
-
依托单位:
Career Development in Diabetes for Pediatric Endocrinolo
-
批准号:6761917
-
项目类别:
-
资助金额:$40.34万
-
财政年份:2002
-
负责人:LORI M LAFFEL
-
依托单位:
Career Development in Diabetes for Pediatric Endocrinolo
-
批准号:7079306
-
项目类别:
-
资助金额:$40.34万
-
财政年份:2002
-
负责人:LORI M LAFFEL
-
依托单位:
Clinical Translational Research Core
-
批准号:10160878
-
项目类别:
-
资助金额:$16.61万
-
财政年份:1997
-
负责人:LORI M LAFFEL
-
依托单位:
海外基金